Cunningham Ann Michelle 4
4 · Vistagen Therapeutics, Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-09-09+17,600→ 17,600 totalExercise: $3.61Exp: 2035-09-09→ Common Stock (17,600 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant.